FDA Inspection 1071935 — Aizant Drug Research Solutions Pvt Ltd., Clinical Pharmacology Unit-II
The FDA completed an inspection of Aizant Drug Research Solutions Pvt Ltd., Clinical Pharmacology Unit-II on September 21, 2018 in Hyderabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 21, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hyderabad (India)
Additional Details
Clinical BA/BE